Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma
- 420 Downloads
Pulmonary fibrosis is associated with irreversible, or partially reversible, airflow obstruction and ultimately unresponsiveness to asthma therapies such as corticosteroids. Intranasal curcumin, an anti-inflammatory molecule, has been found effective in allergic asthma. To study the effect of intranasal curcumin on airway remodeling and fibrosis in murine model of chronic asthma, BALB/c mice were sensitized to ovalbumin (OVA) and exposed to OVA aerosol (2%) from day 21 (after sensitization) for 5 weeks (twice/week). Curcumin (intranasal) was administered during the OVA aerosol challenge. Mice exposed to OVA developed inflammation dominated by eosinophils which lead to fibrosis and airway remodeling. Intranasal administration of curcumin significantly inhibited airway inflammation and pulmonary fibrosis, where MMP-9 activities were decreased along with α-smooth muscle actin (α-SMA), MMP-9, TIMP-1, and eotaxin expressions. These results suggest that intranasal curcumin regulates airway inflammation and remodeling in chronic asthma.
KEY WORDSextracellular matrix fibrosis anti-inflammatory airway remodeling
Authors are thankful to Department of Science and Technology - Science and Engineering Research Board, (DST-SERB) and Council of Scientific and Industrial Research, India for financial assistance.
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflict of interest.
- 2.Conroy, D.M., and T.J. Williams. 2001. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respiratory Research 2: 1.Google Scholar
- 14.Kamboj, V.P. 2000. Herbal medicine. Current Science 78: 35–38.Google Scholar
- 35.Mautino, G., C. Henriquet, C. Gougat, et al. 1999. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Laboratory investigation. A Journal of Technical Methods and Pathology 79: 39–47.Google Scholar
- 40.Cataldo, D.D., J. Bettiol, A. Noël, P. Bartsch, J.M. Foidart, and R. Louis. 2002. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. CHEST Journal 122: 1553–1559.CrossRefGoogle Scholar